Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_assertion type Assertion NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_head.
- NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_assertion description "[Only 5.7% (2/35) of anaplastic oligodendrogliomas showed CD117 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_provenance.
- NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_assertion evidence source_evidence_literature NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_provenance.
- NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_assertion SIO_000772 17726262 NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_provenance.
- NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_assertion wasDerivedFrom befree-20150227 NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_provenance.
- NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_assertion wasGeneratedBy ECO_0000203 NP525826.RAShHv39PNrqaI3_kndzqTx_5v9nZW64HioyIfnS83eFY130_provenance.